Onward Medical N.V. (ONWRY)
OTCMKTS · Delayed Price · Currency is USD
5.10
-0.01 (-0.12%)
Feb 11, 2026, 9:46 AM EST
Onward Medical Employees
Onward Medical had 103 employees as of December 31, 2024. The number of employees increased by 3 or 3.38% compared to the previous year.
Employees
103
Change (1Y)
3
Growth (1Y)
3.38%
Revenue / Employee
$30,968
Profits / Employee
-$440,696
Market Cap
222.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103 | 3 | 3.38% |
| Dec 31, 2023 | 99 | 3 | 3.23% |
| Dec 31, 2022 | 96 | 19 | 24.97% |
| Dec 31, 2021 | 77 | 22 | 39.82% |
| Dec 31, 2020 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| First Northern Community Bancorp | 187 |
| South Dakota Soybean Processors, LLC | 139 |
| Malaga Financial | 73 |
| Cardinal Ethanol, LLC | 72 |
| Helios Fairfax Partners | 14 |
| Wewards | 1 |
Onward Medical News
- 8 days ago - ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury - GlobeNewsWire
- 21 days ago - ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement - GlobeNewsWire
- 2 months ago - ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 - GlobeNewsWire
- 3 months ago - ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use - GlobeNewsWire
- 3 months ago - ONWARD Medical Publishes Closing of Bookbuild Offering - GlobeNewsWire
- 3 months ago - ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase - GlobeNewsWire
- 4 months ago - ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States - GlobeNewsWire
- 4 months ago - Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 - GlobeNewsWire